CVE-2022-31048

Cross-Site Scripting in Form Framework

Description

TYPO3 is an open source web content management system. Prior to versions 8.7.47 ELTS, 9.5.34 ELTS, 10.4.29, and 11.5.11, the Form Designer backend module of the Form Framework is vulnerable to cross-site scripting. A valid backend user account with access to the form module is needed to exploit this vulnerability. TYPO3 versions 8.7.47 ELTS, 9.5.34 ELTS, 10.4.29, and 11.5.11 contain a fix for the problem.

Category

5.4
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.51%
Vendor Advisory typo3.org
Affected: TYPO3 typo3
Published at:
Updated at:

References

Link Tags
https://github.com/TYPO3/typo3/security/advisories/GHSA-3r95-23jp-mhvg third party advisory
https://github.com/TYPO3/typo3/commit/6f2554dc4ea0b670fd5599c54fd788d4db96c4a0 third party advisory patch
https://typo3.org/security/advisory/typo3-core-sa-2022-003 vendor advisory

Frequently Asked Questions

What is the severity of CVE-2022-31048?
CVE-2022-31048 has been scored as a medium severity vulnerability.
How to fix CVE-2022-31048?
To fix CVE-2022-31048, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-31048 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2022-31048 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-31048?
CVE-2022-31048 affects TYPO3 typo3.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.